The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

During severe inflammatory and infectious diseases, various mediators modulate the
equilibrium of vascular tone, inflammation, coagulation and thrombosis. This Review …

The novel coronavirus disease (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. The …

Background: The National Health and Nutrition Examination Survey data indicate that the
proportion of US adults with hypertension that had controlled blood pressure (BP) declined …

Aim This review aims to summarize and discuss some of the most relevant clinical trials in
epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021. Data …

Background From the beginning of the COVID-19 pandemic, age (most importantly), male
gender and various comorbidities were found to be associated with severe forms of COVID …

Seventeen years after the epidemic of SARS coronavirus, a novel coronavirus SARS-CoV-2-
emerged resulting in an unprecedented pandemic. Angiotensin-converting enzyme 2 …

Importance SARS-CoV-2 viral entry may disrupt angiotensin II (AII) homeostasis,
contributing to COVID-19 induced lung injury. AII type 1 receptor blockade mitigates lung …

We propose a modified self‐controlled case series (SCCS) method to handle both event‐
dependent exposures and high event‐related mortality. This development is motivated by an …

Abstract SARS-CoV-2, the virus responsible for COVID-19, uses angiotensin converting
enzyme 2 (ACE2) as its primary cell-surface receptor. ACE2 is a key enzyme in the counter …